CORDIS · 315549 · FP7
BRAINSAFE II Development of a Novel Autonomous Non-Invasive Absolute Intracranial Pressure Measurement Device Based on Ultrasound Doppler Technology
Coordinator: UAB Vittamed (LT)
The BrainSafe II project builds upon a successful Research for the Benefit of SMEs project and will deliver an innovative technology for the autonomous, calibration free, non-invasive, rapid, accurate and precise absolute intracranial pressure (aICP) determination. The resultant device will exhibit absolute intracranial pressure measurement to within SD = ± 2,5 mmHg. The target time for the whole procedure is 9 minutes (compared with a current average 23 minutes). The device resulting from this research will be a very significant breakthrough in healthcare delivery. The timely application of …
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €1.3M awarded to the consortium. The project runs over approximately 2 years from 2012-09-01 to 2014-08-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from LT
see all →- SustAInLivWork — Centre of Excellence of AI for Sustainable Living and Working101059903 · HORIZON · €14.7M
- SUPER PV — CoSt redUction and enhanced PERformance of PV systems792245 · H2020 · €9.9M
- Forest 4.0 — Creation of the centre of excellence in smart forestry101059985 · HORIZON · €9.9M
- FemtoSurf — Functional surface treatments using ultra-short pulse laser system FemtoSurf825512 · H2020 · €7.0M
- GIFFT — Sustainable Glass Industry with Fuel-Flexible Technology101122257 · HORIZON · €4.5M
- EnergyKeeper — Keep the Energy at the right place!731239 · H2020 · €4.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the BSG-SME funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.3M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by UAB Vittamed (LT).
- What is the project timeline?
- The project runs from 2012-09-01 to 2014-08-31 — approximately 2 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 315549.